AU2003255893A1 - USE OF A PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR ALPHA (PPAR $f(a)) AGONIST FOR THE TREATMENT OF CARNITINE PALMITOYL TRANSFERASE-2 DEFICIENCIES - Google Patents

USE OF A PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR ALPHA (PPAR $f(a)) AGONIST FOR THE TREATMENT OF CARNITINE PALMITOYL TRANSFERASE-2 DEFICIENCIES

Info

Publication number
AU2003255893A1
AU2003255893A1 AU2003255893A AU2003255893A AU2003255893A1 AU 2003255893 A1 AU2003255893 A1 AU 2003255893A1 AU 2003255893 A AU2003255893 A AU 2003255893A AU 2003255893 A AU2003255893 A AU 2003255893A AU 2003255893 A1 AU2003255893 A1 AU 2003255893A1
Authority
AU
Australia
Prior art keywords
ppar
agonist
deficiencies
treatment
activated receptor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003255893A
Inventor
Jean Bastin
Fatima Djouadi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut National de la Sante et de la Recherche Medicale INSERM
Original Assignee
Institut National de la Sante et de la Recherche Medicale INSERM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut National de la Sante et de la Recherche Medicale INSERM filed Critical Institut National de la Sante et de la Recherche Medicale INSERM
Publication of AU2003255893A1 publication Critical patent/AU2003255893A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2003255893A 2002-09-03 2003-08-26 USE OF A PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR ALPHA (PPAR $f(a)) AGONIST FOR THE TREATMENT OF CARNITINE PALMITOYL TRANSFERASE-2 DEFICIENCIES Abandoned AU2003255893A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US40725302P 2002-09-03 2002-09-03
US60/407,253 2002-09-03
PCT/IB2003/003527 WO2004022047A1 (en) 2002-09-03 2003-08-26 USE OF A PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR ALPHA (PPAR $f(a)) AGONIST FOR THE TREATMENT OF CARNITINE PALMITOYL TRANSFERASE-2 DEFICIENCIES

Publications (1)

Publication Number Publication Date
AU2003255893A1 true AU2003255893A1 (en) 2004-03-29

Family

ID=31978447

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003255893A Abandoned AU2003255893A1 (en) 2002-09-03 2003-08-26 USE OF A PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR ALPHA (PPAR $f(a)) AGONIST FOR THE TREATMENT OF CARNITINE PALMITOYL TRANSFERASE-2 DEFICIENCIES

Country Status (2)

Country Link
AU (1) AU2003255893A1 (en)
WO (1) WO2004022047A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3015287B1 (en) * 2013-12-19 2016-12-23 Inst Nat Sante Rech Med COMBINATION OF BEZAFIBRATE AND RESVERATROL FOR THE TREATMENT AND PREVENTION OF DISEASES INVOLVING AN ENERGY DYSFUNCTION OF MITOCHONDRIES.

Also Published As

Publication number Publication date
WO2004022047A1 (en) 2004-03-18

Similar Documents

Publication Publication Date Title
HK1068870A1 (en) Substituted phenylpropionic acid derivatives as agonists to human peroxisome proliferator-activated receptor alpha (ppar)
HK1058790A1 (en) Peroxisome proliferator activated receptor alpha agonists
IL158873A0 (en) Modulators of peroxisome proliferator activated receptors
AU2003287965A1 (en) Modulation of peroxisome proliferator activated receptors activity
IL163768A0 (en) Thiazole and oxazole derivatives that modulate ppar activity
HK1075080A1 (en) Threaded pipe with surface treatment
IL161578A0 (en) Peroxisome proliferator activated receptor agonists
AU2003279442A8 (en) 2-thiohydantoine derivative compounds and use thereof for the treatment of diabetes
AU2003225027A1 (en) Combination therapy using a ppar alpha/gamma agonist
AU2003278814A8 (en) Ligands for the peroxisome proliferator-activated receptor, and methods of use thereof
HK1074402A1 (en) Use of amide derivative of ge 2270 factor a3 for the treatment of acne
AU2002347985A1 (en) Peroxisome proliferator activated receptor alpha agonists
AU2003272608A1 (en) Modulating vesicular monoamine transporter trafficking and function: a novel approach for the treatment of parkinson's disease
SI1569634T1 (en) Use of a ppar-alpha agonist and metformin for the treatment of obesity
AU2003255893A1 (en) USE OF A PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR ALPHA (PPAR $f(a)) AGONIST FOR THE TREATMENT OF CARNITINE PALMITOYL TRANSFERASE-2 DEFICIENCIES
AU2003303376A1 (en) Cannabinoid analogs as peroxisome proliferator activated nuclear receptor gamma activators
AU2003238249A8 (en) Use of peroxisome proliferator activated receptor (ppar)-gamma ligands as a treatment for pituitary tumors and associated conditions, such as cushing's syndrome
AU2003277665A1 (en) Peroxisome proliferator-activated recetor ligand
AU2003261927A1 (en) Peroxisome proliferator-activated receptor controllers
AU2003232785A1 (en) Novel anthracene derivatives and the use thereof as a medicament
AU2003246187A1 (en) MEDICINAL COMPOSITION CONTAINING DIURETIC AND PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR (PPAR) Gamma ACTIAVTOR
AU2003259759A1 (en) Gal3 receptor antagonists for the treatment of affective disorders
AU2002232243A1 (en) Activator for peroxisome proliferator-activated receptor
AU2003293295A8 (en) Use of a propargyl alcohol enantiomer for the treatment of dermatological disorders
AU2003218172A1 (en) Take-up shaft for cleaning cylinder device

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase